Biotech Target N V - May 16, 2022 Form 4 Insider Report for Molecular Templates, Inc. (MTEM)

Role
10%+ Owner
Signature
/s/ Ivo Betschart
Stock symbol
MTEM
Transactions as of
May 16, 2022
Transactions value $
$236,200
Form type
4
Date filed
5/18/2022, 12:21 PM
Previous filing
Jan 10, 2022
Next filing
May 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTEM Common Stock Purchase $236K +200K +1.82% $1.18 11.2M May 16, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.